Identification of AK4 as a novel therapeutic target for serous ovarian cancer

The present study aimed to assess the expression level of adenylate kinase 4 (AK4) in human serous ovarian cancer (SOC) tissues and investigate the possible involvement of AK4 in SOC progression. Bioinformatics analysis based on The Cancer Genome Atlas (TCGA) database and immunohistochemical (IHC) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Minmin, Qin, Xinlei, Wang, Yuwei, Mao, Furong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583734/
https://www.ncbi.nlm.nih.gov/pubmed/33123257
http://dx.doi.org/10.3892/ol.2020.12209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7583734/
https://www.ncbi.nlm.nih.gov/pubmed/33123257
http://dx.doi.org/10.3892/ol.2020.12209

Ejemplares similares